-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Titan Medical Inc. (NASDAQ:TMDI) Shares Bought by Essex LLC
Titan Medical Inc. (NASDAQ:TMDI) Shares Bought by Essex LLC
Essex LLC lifted its holdings in shares of Titan Medical Inc. (NASDAQ:TMDI – Get Rating) by 17.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,364,218 shares of the company's stock after buying an additional 359,581 shares during the period. Essex LLC's holdings in Titan Medical were worth $1,064,000 at the end of the most recent reporting period.
Separately, JPMorgan Chase & Co. raised its stake in shares of Titan Medical by 70.9% during the 1st quarter. JPMorgan Chase & Co. now owns 126,600 shares of the company's stock worth $67,000 after buying an additional 52,500 shares during the period. Institutional investors own 3.55% of the company's stock.
Get Titan Medical alerts:Titan Medical Trading Up 4.6 %
Shares of TMDI stock traded up $0.04 during trading hours on Friday, hitting $0.88. 212,696 shares of the company's stock were exchanged, compared to its average volume of 432,199. The firm has a 50 day moving average of $0.73 and a two-hundred day moving average of $0.57. Titan Medical Inc. has a fifty-two week low of $0.38 and a fifty-two week high of $1.20.
Titan Medical (NASDAQ:TMDI – Get Rating) last announced its earnings results on Thursday, November 10th. The company reported ($0.09) earnings per share for the quarter.About Titan Medical
(Get Rating)
Titan Medical, Inc engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation.
See Also
- Get a free copy of the StockNews.com research report on Titan Medical (TMDI)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
Want to see what other hedge funds are holding TMDI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Titan Medical Inc. (NASDAQ:TMDI – Get Rating).
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Essex LLC lifted its holdings in shares of Titan Medical Inc. (NASDAQ:TMDI – Get Rating) by 17.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,364,218 shares of the company's stock after buying an additional 359,581 shares during the period. Essex LLC's holdings in Titan Medical were worth $1,064,000 at the end of the most recent reporting period.
HoldingSchannel报道,Essex LLC在第三季度将其持有的泰坦医疗公司(纳斯达克股票代码:TMDI — 获取评级)的股票增加了17.9%。该机构投资者在此期间又购买了359,581股股票后,拥有该公司2,364,218股股票。在最近一个报告期结束时,Essex LLC在Titan Medical的持股价值为1,064,000美元。
Separately, JPMorgan Chase & Co. raised its stake in shares of Titan Medical by 70.9% during the 1st quarter. JPMorgan Chase & Co. now owns 126,600 shares of the company's stock worth $67,000 after buying an additional 52,500 shares during the period. Institutional investors own 3.55% of the company's stock.
另外,摩根大通在第一季度将其在泰坦医疗的股份提高了70.9%。摩根大通在此期间又购买了52,500股股票后,现在拥有该公司126,600股股票,价值67,000美元。机构投资者拥有该公司3.55%的股票。
Titan Medical Trading Up 4.6 %
泰坦医疗交易上涨4.6%
Shares of TMDI stock traded up $0.04 during trading hours on Friday, hitting $0.88. 212,696 shares of the company's stock were exchanged, compared to its average volume of 432,199. The firm has a 50 day moving average of $0.73 and a two-hundred day moving average of $0.57. Titan Medical Inc. has a fifty-two week low of $0.38 and a fifty-two week high of $1.20.
TMDI股票在周五的交易时段上涨了0.04美元,达到0.88美元。该公司股票交易了212,696股,而平均交易量为432,199股。该公司的50天移动平均线为0.73美元,两百天移动平均线为0.57美元。Titan Medical Inc.创下五十二周低点0.38美元,五十二周高点为1.20美元。
About Titan Medical
关于泰坦医疗
(Get Rating)
(获取评分)
Titan Medical, Inc engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation.
Titan Medical, Inc从事计算机辅助机器人手术技术的研究和开发,该技术应用于微创手术(MIS)。其产品组合Enos系统是一种机器人单通道手术,具有双三维和二维清晰度视觉系统、多关节仪器和外科医生工作站。
See Also
另见
- Get a free copy of the StockNews.com research report on Titan Medical (TMDI)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- 免费获取 StockNews.com 关于 Titan Medical (TMDI) 的研究报告
- MarketBeat Week 回顾 — 1/23-1/27
- 为什么 Lucid 在一天之内飙升了近 100%
- 利用这些铁路股票实现增长和收入
- ASML 预计今年对芯片的需求将上涨,提振了销售前景
- KLA 公司:在陷入困境的半市场中的实力
Want to see what other hedge funds are holding TMDI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Titan Medical Inc. (NASDAQ:TMDI – Get Rating).
想看看还有哪些对冲基金持有 TMDI 吗? 访问Holdingschannel.com,获取泰坦医疗公司(纳斯达克股票代码:TMDI — 获取评级)的最新13F文件和内幕交易。
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收《泰坦医学日报》的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Titan Medical及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧